NCT06764511View on ClinicalTrials.gov

Evaluation of Response to Biosimilar Erythropoietin Alfa Therapy in Anemic Patients With Myelodysplastic Syndrome

RecruitingOBSERVATIONAL

Enrollment

60

Participants

Timeline

Start Date

August 30, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions

Myelodysplastic Syndromes (MDS)

Trial Locations (1)

40138

RECRUITING

IRCCS Azienda Ospedaliera -Universitaria di Bologna, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER